July 2023 Venture Growth Funding Recap

Growthink Capital Research tracked $2.79 billion in new venture funding in July 2023, compared to the $4.36 billion tracked in June 2023.

The month’s biggest funding event belonged to Smile Doctors ($550 million) a dental support organization (DSO) intended to provide all-inclusive orthodontic treatments to patients helping its patients to get beautiful smiles and attain confidence.

—————————————————————————————————————-

Take our Financing Test. If you had additional capital, could you use it to grow your company? Or to fund a liquidity event for you and your shareholders?

We’ve built a unique network of investors looking to invest in companies with the right, key characteristics.

To see if your company has them, take our “Financing Test.”

—————————————————————————————————————-

Three companies raised $100 million or more in July. Other than Smile Doctors, the other two companies that raised the most are as follows:

  1. Clair ($175 million) an instant pay access technology intended to develop a gig economy enabling human capital management teams to help maintain the financial health of workers.
  2. Author Health ($115 million) a comprehensive behavioral healthcare platform intended for serious mental illness enabling senior patients to receive virtual and in-person mental healthcare services they need in the setting that is convenient for them.

The hottest sectors for funding during the month were A.I./Machine Learning, Biotech, Healthtech, Cryptocurrency/Blockchain, and Financial Software.

Key funding events in each of these sectors for the month are below:

  1. A.I./Machine Learning deals included Unstructured ($25 million), Pano ($17 million), Topline Pro ($12 million), Peaxy ($12 million), Akooda ($11 million), CompScience ($10 million), RecruitBot ($8.2 million), Ubicept ($8 million), and Revolear ($6 million).
  2. Biotech deals included Ossium Health ($52 million), Empress Therapeutics ($50 million), Kincell Bio ($36 million), SURGE Therapeutics ($32 million), CoJourney ($30 million), A-Alpha Bio ($22 million), Verismo Therapeutics ($17 million), and Kayothera ($5.2 million).
  3. Healthtech deals included RapidAI ($75 million), Octave Bioscience ($30 million), Siphox Health ($27 million), Verifiable ($27 million), K4Connect ($8.9 million), Eureka Health ($7 million), and Fold Health ($6 million).
  4. Cryptocurrency/Blockchain deals included Futureverse ($54 million), RISC Zero ($40 million), Cosmic Wire ($30 million), Opolis ($6.6 million), and LunarCrush ($5 million).
  5. Financial Software deals included Collective Hub ($50 million), Jirav ($20 million), Immediate ($16 million), and Finicast ($13 million).

—————————————————————————————————————

Take our Fundability Test. If you had additional capital, could you use it to grow your company? Or to fund a liquidity event for you and your shareholders?

We’ve built a unique network of investors looking to invest in companies with the right, key characteristics.

To see if your company has them, take our “Fundability Test.”

—————————————————————————————————————

If you’re looking for outside funding to grow your company, please don’t hesitate to call us at (213) 927-3968 or fill out Growthink Capital’s contact form here.

Let Our Experts Help You

Get a Free Consultation

Recent Posts